Search results

Order by most recent / most popular / relevance

Results: 1-3 of 3

Canada's version of the responsible corporate officer doctrine: can officers be held responsible for pharma violations?

Torys LLP
-
Canada, USA
-
February 29 2012

In March 2010, the United States Food and Drug Administration (FDA) announced its intention to rely more heavily on the "responsible corporate officer" (RCO) doctrine to prosecute individuals for violations of the federal Food, Drug and Cosmetic Act (FDCA

Recent prison sentences demonstrate increased exposure for corporate officers

Holland & Knight LLP
-
USA
-
November 29 2011

Last week, three former executives of a medical device company were sentenced to federal prison terms for their roles in managing a company that marketed a device for an unauthorized use and conducted unauthorized clinical trials that were associated with the deaths of three participants

Investor actions deadlines eased by court

Norton Rose Fulbright LLP
-
USA
-
May 10 2010

The US Supreme Court relaxed the deadlines for shareholder fraud actions, allowing investors to proceed with accusations that Merck & Co, the pharmaceutical company, misled the public about the health risks posed by its Vioxx painkiller, which was withdrawn because of links to heart attacks and strokes

Current Search

Jurisdiction - USA
Workarea - Company & Commercial
Workarea - Healthcare
Workarea - Litigation
Workarea - Product Liability

Search results

Canada's version of the responsible corporate officer doctrine: can officers be held responsible for pharma violations?

Recent prison sentences demonstrate increased exposure for corporate officers

Investor actions deadlines eased by court

Current Search

Suggested Facets

Author

Firm Name